Eva Tuomilehto‐Wolf

9.7k citations

69 papers · 3.6k indexed · 1 hit paper · h-index 24

Surgery top 1%
Genetics top 1%
Endocrinology, Diabetes and Metabolism top 0.5%
Cardiology and Cardiovascular Medicine top 5%
Immunology top 5%

Co-authors: L. Toivanen Kimmo Kohtamäki J. Tuomilehto Jari Stengård Paul Zimmet Gabriele Vidgrén Lauren Grace Mackey Pentti Koskela
Topics: Diabetes and associated disorders (49 papers)Pancreatic function and diabetes (31 papers)Diabetes Management and Research (19 papers)
Cited by: Endocrinology, Diabetes and Metabolism Genetics Surgery
Journals: The Lancet Nature Genetics PLoS ONE
Partner nations: Finland United Kingdom United States

In The Last Decade

Eva Tuomilehto‐Wolf

69 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease

1994 1.5k citations J. Tuomilehto, Gabriele Vidgrén et al. The Lancet profile →

Peers

Countries citing papers authored by Eva Tuomilehto‐Wolf

Since Specialization

Citations

This map shows the geographic impact of Eva Tuomilehto‐Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Tuomilehto‐Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Tuomilehto‐Wolf more than expected).

Fields of papers citing papers by Eva Tuomilehto‐Wolf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Tuomilehto‐Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Tuomilehto‐Wolf. The network helps show where Eva Tuomilehto‐Wolf may publish in the future.

Co-authorship network of co-authors of Eva Tuomilehto‐Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Tuomilehto‐Wolf. A scholar is included among the top collaborators of Eva Tuomilehto‐Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Tuomilehto‐Wolf. Eva Tuomilehto‐Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Convincing statistical support for association of the Arg620Trp polymorphism in PTPN22 locus with Type 1 diabetes 2004 ·Diabetologia ·Adrian Vella,Deborah J. Smyth,Jonathan D. Cooper,Eva Tuomilehto‐Wolf,J. Tuomilehto,D E Undlien,(unknown),Cristian Guja,C Ionescu-Tîrgovişte,(unknown),David B. Dunger,D P Strachan,(unknown),John A. Todd	1
2	Class I and II HLA Genes Are Associated with Susceptibility and Age at Onset in Finnish Families with Type 1 Diabetes 2004 ·Human Heredity ·Janne Pitkäniemi,Timo Hakulinen,(unknown),Eva Tuomilehto‐Wolf,Jaakko Tuomilehto	6
3	Comparative high-resolution analysis of linkage disequilibrium and tag single nucleotide polymorphisms between populations in the vitamin D receptor gene 2004 ·Human Molecular Genetics ·Sergey Nejentsev,Lisa Godfrey,(unknown),Helen Rance,Sarah Nutland,Neil Walker,Alexander Lam,Cristian Guja,C Ionescu-Tîrgovişte,Dag E. Undlien,Kjersti S. Rønningen,Eva Tuomilehto‐Wolf,Jaakko Tuomilehto,Melanie J. Newport,David Clayton,John A. Todd	164
4	Occurrence of chronic inflammatory rheumatic diseases among parents of multiple offspring affected by juvenile idiopathic arthritis. 2003 ·PubMed ·Hanna Säilä,A Savolainen,Markku Kauppi,Noora Alakulppi,Eva Tuomilehto‐Wolf,J. Tuomilehto,Marjatta Leirisalo‐Repo,Kimmo Aho	6
5	Estimation of Transmission Probabilities in Families Ascertained through a Proband with Variable Age-at-Onset Disease: Application to the HLA A, B and DR Loci in Finnish Families with Type 1 Diabetes 2000 ·Human Heredity ·Janne Pitkäniemi,Päivi Onkamo,Elja Arjas,Eva Tuomilehto‐Wolf,Jaakko Tuomilehto	5
6	Type 1 diabetes in the offspring does not increase the risk of parental Type 2 diabetes in South Indians 1999 ·Diabetes/Metabolism Research and Reviews ·Anupama Ramachandran,Chamukuttan Snehalatha,Eva Tuomilehto‐Wolf,Gabriele Vidgrén,B Ogunkolade,Vijay Viswanathan,G. A. Hitman	5
7	Record-high incidence of Type I (insulin-dependent) diabetes mellitus in Finnish children 1999 ·Diabetologia ·Jaakko Tuomilehto,M. Karvonen,Janne Pitkäniemi,Esa Virtala,Kimmo Kohtamäki,L. Toivanen,Eva Tuomilehto‐Wolf	120
8	Evaluation of TAP1 polymorphisms with insulin dependent diabetes mellitus in finnish diabetic patients 1997 ·Human Immunology ·Liandong Ma,Alfred Penfornis,(unknown),David Schoenfeld,Eva Tuomilehto‐Wolf,(unknown),G. A. Hitman,Denise L. Faustman	16
9	HLA‐DR4 SUBTYPE AND ‐B ALLELES IN DQB10302‐POSITIVE HAPLOTYPES ASSOCIATED WITH IDDM 1997 ·European Journal of Immunogenetics* ·Helena Reijonen,Sergei Nejentsev,(unknown),Sinikka Koskinen,Eva Tuomilehto‐Wolf,Hans K. Åkerblom,Jorma Ilonen,(unknown)	24
10	Insulin receptor substrate-1 gene mutations in NIDDM; implications for the study of polygenic disease 1995 ·Diabetologia ·G. A. Hitman,K. Hawrami,Mark I. McCarthy,Viswanathan Mohan,C. Snehalatha,(unknown),(unknown),Eva Tuomilehto‐Wolf,Aulikki Nissinen,Oluf Pedersen	11
11	Insulin receptor substrate-1 gene mutations in NIDDM; implications for the study of polygenic disease 1995 ·Diabetologia ·G. A. Hitman,K. Hawrami,Mark I. McCarthy,Viswanathan Mohan,Chamukuttan Snehalatha,(unknown),J. Tuomilehto,Eva Tuomilehto‐Wolf,Aulikki Nissinen,Oluf Pedersen	94
12	In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk 1995 ·Diabetologia ·Kelly Metcalfe,G. A. Hitman,Michael Fennessy,Mark I. McCarthy,Jaakko Tuomilehto,Eva Tuomilehto‐Wolf,(unknown)	25
13	A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population 1994 ·Diabetologia ·Michael Fennessy,Kelly Metcalfe,G. A. Hitman,Mark Niven,P A Biro,Jaakko Tuomilehto,Eva Tuomilehto‐Wolf,(unknown)	80
14	IDDM susceptibility associated with polymorphisms in the insulin gene region A study of blacks, Caucasians and orientals 1994 ·Diabetologia ·Dag E. Undlien,Kazuyuki Hamaguchi,Akinori Kimura,Eva Tuomilehto‐Wolf,A.B.M. Swai,D G McLarty,Jaakko Tuomilehto,Erik Thorsby,(unknown)	23
15	Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of diseasebreakdown → 1994 ·The Lancet ·J. Tuomilehto,Gabriele Vidgrén,L. Toivanen,Eva Tuomilehto‐Wolf,Kimmo Kohtamäki,Jari Stengård,Paul Zimmet,Lauren Grace Mackey,(unknown),Pentti Koskela	1461
16	Glucokinase Gene Polymorphisms: a Genetic Marker for Glucose Intolerance in a Cohort of Elderly Finnish Men 1994 ·Diabetic Medicine ·Mark I. McCarthy,G. A. Hitman,Megan P. Hitchins,Anne Riikonen,Jari Stengård,Aulikki Nissinen,Eva Tuomilehto‐Wolf,Jaakko Tuomilehto	15
17	DQA1 and DQB1 Heterodimers in Insulin-dependent Diabetes Mellitus: A Genetic-epidemiological Study in Finland 1992 ·Annals of Medicine ·Eva Tuomilehto‐Wolf,Jaakko Tuomilehto,G. A. Hitman,(unknown)	6
18	Increasing trend in Type 1 (insulin-dependent) diabetes mellitus in childhood in Finland 1991 ·Diabetologia ·Jaakko Tuomilehto,Marian Rewers,Antti Reunanen,(unknown),R Lounamaa,Eva Tuomilehto‐Wolf,H. K. �kerblom	80
19	NEW SUSCEPTIBILITY HAPLOTYPE FOR TYPE 1 DIABETES 1989 ·The Lancet ·Eva Tuomilehto‐Wolf,(unknown),Jaakko Tuomilehto,R Lounamaa,(unknown)	62
20	Suppression of autologous mixed leukocyte reaction in type 1 diabetes mellitus by in vivo-activated T lymphocytes 1989 ·Clinical Immunology and Immunopathology ·L Räsänen,Heikki Hyöty,Maili Lehto,Olli Kallioniemi,T Huupponen,Eva Tuomilehto‐Wolf,Jaakko Kaprio,Pauli Leinikki	7

About Eva Tuomilehto‐Wolf

Eva Tuomilehto‐Wolf is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Immunology, having authored 69 papers that have together received 3.6k indexed citations. Recurring topics across this work include Diabetes and associated disorders (49 papers), Pancreatic function and diabetes (31 papers) and Diabetes Management and Research (19 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.3k citations), Genetics (1.6k citations) and Surgery (1.8k citations). Eva Tuomilehto‐Wolf has collaborated with scholars based in Finland, United Kingdom and United States. Frequent co-authors include L. Toivanen, Kimmo Kohtamäki, J. Tuomilehto, Jari Stengård, Paul Zimmet, Gabriele Vidgrén, Lauren Grace Mackey, Pentti Koskela, Jaakko Tuomilehto and Jaakko Tuomilehto. Their work appears in journals such as The Lancet, Nature Genetics and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact